Cancer Genetics is an esteemed peer-reviewed journal dedicated to advancing the field of cancer research through the lens of genetics. Published by Elsevier Science Inc and available in both print (ISSN: 2210-7762) and online (E-ISSN: 2210-7770), this journal aims to provide a platform for the dissemination of high-quality studies that unravel the genetic underpinnings of cancer. Since its inception in 2011, Cancer Genetics has become a significant resource for researchers, professionals, and students with a shared interest in understanding the intricate relationship between genetics and oncogenesis. With an impact factor that reflects its influence, the journal has maintained a Q3 ranking in Cancer Research, Genetics, and Molecular Biology as of 2023, indicating its growing importance in these fields. Additionally, the journal offers open access options to ensure that crucial findings are easily accessible to the global research community. By bridging the gap between genetics and cancer studies, Cancer Genetics plays a pivotal role in fostering innovation and collaboration among scientists and clinicians striving to improve cancer diagnosis and treatment.

Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

TRENDS IN GENETICS, published by CELL PRESS, is a leading journal in the field of genetics, recognized for its significant impact on research and advancements in the discipline. With an impressive Scopus ranking of #10 out of 347 in the category of Genetics and a 97th percentile ranking, this journal stands as a premier platform for publishing innovative, high-quality articles that shape the future of genetic research. Since its inception in 1985, TRENDS IN GENETICS has been at the forefront of the genetic sciences, continuously disseminating crucial findings while maintaining a strong commitment to scientific rigor and integrity. Although it does not currently offer open access options, its rigorous peer-review process ensures that only the most relevant and groundbreaking studies make it to publication. Scholars and practitioners in genetics will find this journal to be an invaluable resource for keeping abreast of the latest developments, trends, and methodologies that drive the field forward.

GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.

Human Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.